YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AstraZeneca enters $6B oncology deal

Posted online

AstraZeneca entered into an oncology collaboration with Daiichi Sankyo Co. that's worth up to $6 billion.

MarketWatch reports the deal could redefine treatment standards in lung, breast and multiple other cancers.

AstraZeneca initially will pay Daiichi Sankyo $1 billion.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences